Biofrontera Inc. (BFRI)
USD 0.8
(-4.64%)
USD 0.8
(-4.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -18.45 Million USD | 4.19% |
| 2022 | 934 Thousand USD | 15.84% |
| 2021 | -36.75 Million USD | -287.64% |
| 2020 | -7.49 Million USD | 25.85% |
| 2019 | -8.14 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -4.76 Million USD | 107.95% |
| 2024 Q1 | -5.46 Million USD | -315.12% |
| 2023 Q3 | -4.62 Million USD | 43.88% |
| 2023 FY | - USD | 4.19% |
| 2023 Q4 | -3.57 Million USD | 22.73% |
| 2023 Q2 | -8.23 Million USD | -43.79% |
| 2023 Q1 | -5.72 Million USD | -7.67% |
| 2022 Q2 | -7.89 Million USD | -172.69% |
| 2022 Q1 | -2.89 Million USD | 37.21% |
| 2022 FY | - USD | 15.84% |
| 2022 Q4 | -5.31 Million USD | 7.16% |
| 2022 Q3 | -5.72 Million USD | 27.48% |
| 2021 FY | - USD | -287.64% |
| 2021 Q4 | -4.61 Million USD | 69.01% |
| 2021 Q3 | -14.88 Million USD | -450.2% |
| 2021 Q2 | -2.7 Million USD | -7.04% |
| 2021 Q1 | -2.52 Million USD | -531.23% |
| 2020 Q2 | -2.36 Million USD | 34.33% |
| 2020 FY | - USD | 25.85% |
| 2020 Q4 | 586 Thousand USD | 133.47% |
| 2020 Q3 | -1.75 Million USD | 26.06% |
| 2020 Q1 | -3.6 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 105.985% |
| Embecta Corp. | 245.4 Million USD | 107.52% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 116.88% |
| Dynavax Technologies Corporation | 9.66 Million USD | 290.906% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 87.707% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 111.328% |
| PainReform Ltd. | -9.56 Million USD | -92.841% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | 1661.168% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -382.505% |
| SCYNEXIS, Inc. | 73.47 Million USD | 125.113% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | -684.897% |
| Cosmos Health Inc. | -17.06 Million USD | -8.154% |
| Journey Medical Corporation | 1.92 Million USD | 1060.593% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | -382.505% |
| Safety Shot Inc | -12.18 Million USD | -51.438% |
| Alpha Teknova, Inc. | -25.53 Million USD | 27.746% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 88.384% |
| Bright Green Corporation | - USD | Infinity% |
| Procaps Group, S.A. | 104.02 Million USD | 117.739% |
| Theratechnologies Inc. | -10.31 Million USD | -78.933% |
| Harrow Health, Inc. | 9.72 Million USD | 289.787% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | -307.801% |
| DURECT Corporation | -24.68 Million USD | 25.243% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 118.779% |
| Cronos Group Inc. | -72.14 Million USD | 74.424% |
| OptiNose, Inc. | -15.55 Million USD | -18.646% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 98.005% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 48.858% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 170.254% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 151.214% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | -370.457% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | -2495.906% |
| Radius Health, Inc. | 38.31 Million USD | 148.168% |
| Universe Pharmaceuticals INC | -3.21 Million USD | -473.953% |
| ProPhase Labs, Inc. | -14.82 Million USD | -24.455% |
| Phibro Animal Health Corporation | 84.6 Million USD | 121.81% |
| Procaps Group S.A. | 104.02 Million USD | 117.739% |
| Alvotech | -484.86 Million USD | 96.194% |
| TherapeuticsMD, Inc. | -8.4 Million USD | -119.652% |
| Viatris Inc. | 3.51 Billion USD | 100.525% |
| Rockwell Medical, Inc. | -4.69 Million USD | -293.119% |
| Aytu BioPharma, Inc. | -1.01 Million USD | -1723.419% |
| SIGA Technologies, Inc. | 84.15 Million USD | 121.926% |
| Tilray Brands, Inc. | -72.84 Million USD | 74.667% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | 2372.537% |
| Shineco, Inc. | -26.55 Million USD | 30.507% |
| PetIQ, Inc. | 81.48 Million USD | 122.646% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | -410.086% |
| Incannex Healthcare Limited | -18.5 Million USD | 0.276% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 104.435% |
| Alimera Sciences, Inc. | 7.27 Million USD | 353.615% |
| Silver Spike Investment Corp. | 7.34 Million USD | 351.4% |
| Assertio Holdings, Inc. | -222.44 Million USD | 91.705% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | -362.406% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | -338.119% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | -9.813% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 7.877% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 87.626% |
| Hempacco Co., Inc. | -12.77 Million USD | -44.466% |
| Talphera, Inc. | -9.84 Million USD | -87.492% |
| Alvotech | -484.86 Million USD | 96.194% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | 123.81% |
| Lantheus Holdings, Inc. | 491 Million USD | 103.758% |
| Currenc Group, Inc. | -1.9 Million USD | -870.917% |
| Kamada Ltd. | 21.53 Million USD | 185.692% |
| Indivior PLC | 66 Million USD | 127.959% |
| Evoke Pharma, Inc. | -7.29 Million USD | -153.048% |
| Flora Growth Corp. | -45.87 Million USD | 59.771% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 7.877% |
| Evolus, Inc. | -41.81 Million USD | 55.865% |
| HUTCHMED (China) Limited | 25.52 Million USD | 172.285% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 107.642% |
| Akanda Corp. | -27.73 Million USD | 33.468% |